Ipsen D-US-60010-001 – NAPOLI 3
An open-label, randomized, multicenter, phase 3 study of irinotecan liposome injection, oxaliplatin, 5-fluorouracil/leucovorin vs nab-paclitaxel plus gemcitabine in subjects who have not previously received chemotherapy for metastatic adenocarcinoma of the pancreas